0001104659-22-060818.txt : 20220516 0001104659-22-060818.hdr.sgml : 20220516 20220516071456 ACCESSION NUMBER: 0001104659-22-060818 CONFORMED SUBMISSION TYPE: 13F-HR/A PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20211231 FILED AS OF DATE: 20220516 DATE AS OF CHANGE: 20220516 EFFECTIVENESS DATE: 20220516 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nextech Invest AG CENTRAL INDEX KEY: 0001911010 IRS NUMBER: 000000000 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR/A SEC ACT: 1934 Act SEC FILE NUMBER: 028-22157 FILM NUMBER: 22925417 BUSINESS ADDRESS: STREET 1: BAHNHOFSTRASSE 18 CITY: ZURICH STATE: V8 ZIP: CH-8001 BUSINESS PHONE: 41 (0)44 366 66 11 MAIL ADDRESS: STREET 1: BAHNHOFSTRASSE 18 CITY: ZURICH STATE: V8 ZIP: CH-8001 13F-HR/A 1 primary_doc.xml 13F-HR/A LIVE false false false 0001911010 XXXXXXXX 12-31-2021 12-31-2021 true 1 RESTATEMENT false Nextech Invest AG
Bahnhofstrasse 18 Zurich V8 CH-8001
13F HOLDINGS REPORT 028-22157 Y This amendment is being filed solely to modify holdings of a certain security that was included in the original Form 13F filed on February 14, 2022.
Marco Weibel Chief Financial Officer 41-44-366-66-11 /s/ Marco Weibel Zurich V8 05-16-2022 0 11 379574
INFORMATION TABLE 2 infotable.xml ARVINAS INC COM 04335A105 23595 287251 SH SOLE 287251 0 0 C4 THERAPEUTICS INC COM STK 12529R107 12103 375857 SH SOLE 375857 0 0 CULLINAN ONCOLOGY INC COM 230031106 18842 1221145 SH SOLE 1221145 0 0 EQRX INC COM 26886C107 89372 13104424 SH SOLE 13104424 0 0 KINNATE BIOPHARMA INC COM 49705R105 53306 3008243 SH SOLE 3008243 0 0 KRONOS BIO INC COM 50107A104 19726 1451537 SH SOLE 1451537 0 0 PMV PHARMACEUTICALS INC COM 69353Y103 32012 1385807 SH SOLE 1385807 0 0 REVOLUTION MEDICINES INC COM 76155X100 74710 2968214 SH SOLE 2968214 0 0 SILVERBACK THERAPEUTICS INC COM 82835W108 12721 1910029 SH SOLE 1910029 0 0 THESEUS PHARMACEUTICALS INC COM 88369M101 7751 611310 SH SOLE 611310 0 0 TYRA BIOSCIENCES INC COM 90240B106 35436 2518582 SH SOLE 2518582 0 0